idarubicin
Showing 26 - 50 of 160
Acute Myeloid Leukemia Trial in Tokyo (Quizartinib, Cytarabine, Idarubicin)
Lymphoma, Non-Hodgkin Trial in Worldwide (Ibrutinib, Rituximab, Ifosfamide)
Acute Myeloid Leukemia, FLT3-mutated Acute Myeloid Leukemia Trial in Japan, Korea, Republic of, Taiwan (gilteritinib,
Active, not recruiting
- Acute Myeloid Leukemia
- FLT3-mutated Acute Myeloid Leukemia
- gilteritinib
- +2 more
-
Anjo, Aichi, Japan
- +54 more
Jan 10, 2023
Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow
Recruiting
- Acute Myeloid Leukemia
- +6 more
- Cladribine
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jan 31, 2022
Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)
Recruiting
- Leukemia, Monocytic, Acute
- Pediatric AML
- Cladribine
- +5 more
-
Foshan, Guangdong, China
- +8 more
Mar 28, 2022
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +16 more
- choline magnesium trisalicylate
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 20, 2021
Leukemia, Myeloid, Acute Trial in Spain (Idarubicin, Ara-C, G-CSF)
Recruiting
- Leukemia, Myeloid, Acute
- Idarubicin
- +5 more
-
Badalona, Barcelona, Spain
- +14 more
Jul 30, 2021
Acute Myeloid Leukemia Trial in United States (CX-01, Idarubicin, Cytarabine)
Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)
Completed
- Leukemia
- Clofarabine
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 17, 2020
Acute Myeloid Leukemia Trial in Augusta, Baltimore (Idarubicin, Cytarabine, Indoximod Freebase)
Completed
- Acute Myeloid Leukemia
- Idarubicin
- +4 more
-
Augusta, Georgia
- +1 more
Jun 3, 2020
Liver Cancer Trial in France (idarubicin, Dc- Beads 300-500µm)
Completed
- Liver Cancer
- idarubicin
- Dc- Beads 300-500µm
-
Amiens, France
- +6 more
Mar 27, 2020
Acute Myeloid Leukemia Trial in Boston (Alisertib, Cytarabine, Idarubicin)
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Durham (Idarubicin, Cytarabine, DLI)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Idarubicin
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Dec 1, 2020
Acute Myeloid Leukemia Trial in Spain (Quizartinib, Fludarabine, Cytarabine)
Active, not recruiting
- Acute Myeloid Leukemia
- Quizartinib
- +4 more
-
Alicante, Spain
- +19 more
Mar 11, 2022
Acute Myeloid Leukemia (AML) Trial in Austria, Germany (Dasatinib, Cytarabine, Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- Dasatinib
- +3 more
-
Innsbruck, Austria
- +53 more
Sep 19, 2022
Acute Myeloid Leukemia Trial in Houston (Crenolanib besylate, Idarubicin, Cytarabine)
Completed
- Acute Myeloid Leukemia
- Crenolanib besylate
- +7 more
-
Houston, TexasMD Anderson Cancer Center
Jul 17, 2020
Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)
Acute Myeloid Leukemia (AML) Trial in France (Idarubicin, Daunorubicin, HD Cytarabine)
Recruiting
- Acute Myeloid Leukemia (AML)
- Idarubicin
- +9 more
-
Amiens, France
- +54 more
Oct 16, 2020
AML in Remission Trial in Fuzhou (Idarubicin, ID cytarabine)
Recruiting
- AML in Remission
- Idarubicin
- ID cytarabine
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Jan 1, 2020
Leukemia Trial in Houston (LY2510924, Idarubicin, Cytarabine)
Completed
- Leukemia
- LY2510924
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 14, 2019
Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)
Active, not recruiting
- Acute Myeloid Leukemia
- Magrolimab
- +6 more
-
Duarte, California
- +25 more
Feb 4, 2022
Acute Myeloid Leukemia Trial in Spain (Quizartinib, Placebo oral tablet, Cytarabine)
Active, not recruiting
- Acute Myeloid Leukemia
- Quizartinib
- +3 more
-
Santiago De Compostela, A Coruña, Spain
- +44 more
Jan 20, 2022